This inventor holds 3 USPTO granted patents. Top assignees: Akita University, Arkay, Inc., Olympus Corporation. Active years: 2010-2018.
Company Filing History:
2 out of 32 
1 out of 3 
1 out of 8,293 
Years Active: 2010-2018
Title: Junichi Ogawa: Innovator in Cancer Detection
Introduction
Junichi Ogawa is a notable inventor based in Akita, Japan. He has made significant contributions to the field of cancer detection, particularly in the area of lymph node metastasis. With a total of 3 patents to his name, Ogawa's work is recognized for its clinical significance and potential impact on treatment strategies.
Latest Patents
One of Ogawa's latest patents is a method for determining lymph node metastasis in cancer or the risk thereof, along with a rapid determination kit for the same. The objective of this invention is to provide a method and means of rapidly and reliably detecting lymph node metastasis in cancer or the risk of such metastasis. Specifically, the invention identifies a certain genetic polymorphism of the human CRP gene, which is clinically significant in determining treatment strategies. This method allows for effective prediction and determination regarding lymph node metastasis, an important phenomenon in cancer progression.
Career Highlights
Throughout his career, Junichi Ogawa has worked with esteemed institutions such as Akita University and Arkay, Inc. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Ogawa has collaborated with notable colleagues, including Masatomo Miura and Satoru Motoyama. These collaborations have further enhanced his research and development efforts in the field of cancer detection.
Conclusion
Junichi Ogawa's innovative work in cancer detection, particularly regarding lymph node metastasis, showcases his commitment to advancing medical science. His contributions are vital for improving treatment strategies and patient outcomes in cancer care.